A study highlights a gap in cancer prevention, showing men undergo genetic testing less often yet are more likely to carry high-risk cancer variants.

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the MyChoice ® CDx ...

Germline testing is a genetic screening that looks for inherited gene mutations found in every cell.  It can identify ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

Of the many advances in science and technology over the past 25 years, genetic testing is arguably one of the most notable. Once a rare part of health care, it is now becoming much more common. It’s ...

Germline testing can identify hereditary cancer, which leads to implications for family members, cascade testing for relatives, and starting surveillance and prevention measures: Genetic testing in ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

Eligible patients can receive up to 70 per cent in subsidies for genetic tests, while MediShield Life coverage will be extended to selected risk-reducing surgical procedures.

Add Yahoo as a preferred source to see more of our stories on Google. Katie Kaye My mum was so young when I lost her to breast cancer. She was only 35. I was eight and my sister Charlotte was nine.

“Breast cancer was the furthest thing from my mind,” Jacob Johnson tells PEOPLE ...

Myriad Genetics Inc, a leader in molecular diagnostic testing and precision medicine, announced that the US Food and Drug Administration (FDA) has approved the MyChoice CDx test as the companion ...